<DOC>
	<DOC>NCT00139594</DOC>
	<brief_summary>This extension study is designed to assess the long-tem tolerability and safety of licarbazepine in patients who completed the 6-week double-blind study CLIC477D2303.</brief_summary>
	<brief_title>Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>written informed consent provided prior to participation in the extension study successful completion of study CLIC477D2303 cooperation and willingness to comply with all study requirements premature discontinuation from study CLIC477D2303 failure to comply with study CLIC477D2303</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Bipolar disorder, manic episode/treatment/licarbazepine</keyword>
</DOC>